Comparison between 68Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 120 (1) , 688-696
Abstract
No abstract availableKeywords
Funding Information
- Chang Gung Memorial Hospital (CPRPG1G0011, CPRPG1G0012, CPRPG1G0013)
- Taiwanese Ministry of Health and Welfare (MOHW109-TDU-B-212-114005)
This publication has 34 references indexed in Scilit:
- Urologic cancer in TaiwanJapanese Journal of Clinical Oncology, 2016
- Detection of locally radio-recurrent prostate cancer at multiparametric MRI: Can dynamic contrast-enhanced imaging be omitted?Diagnostic and Interventional Imaging, 2016
- Current use of PSMA–PET in prostate cancer managementNature Reviews Urology, 2016
- Diagnosis of recurrent prostate cancer and its mimics at multiparametric prostate MRIBritish Journal of Radiology, 2015
- Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical ProstatectomyJournal of Nuclear Medicine, 2015
- The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Metastases in Normal-sized Pelvic Lymph Nodes: Detection with Diffusion-weighted MR ImagingRadiology, 2014
- Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate CancerPharmaceuticals, 2014
- Imaging techniques for local recurrence of prostate cancer: For whom, why and how?Diagnostic and Interventional Imaging, 2012
- 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET ImagingBioconjugate Chemistry, 2012